(Q40958072)

25 September 2017

1 reference

title

P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance (English)

1 reference

25 September 2017

Newcomb EW

1

1 reference

25 September 2017

language of work or name

1 reference

1 April 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

17

1 reference

25 September 2017

issue

3-4

1 reference

25 September 2017

page(s)

211-221

1 reference

The p53 tumour suppressor gene

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Clinical implications of the p53 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53: at the crossroads of molecular carcinogenesis and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Apoptosis: final control point in cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53 function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

The tumor suppressor p53 regulates its own transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Regulation of the specific DNA binding function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Wild-type p53 binds to the TATA-binding protein and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Physical and functional interaction between WT1 and p53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Absence of hereditary p53 mutations in 10 familial leukemia pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Genetic Alteration of p53 in Some Patients with Adult T-Cell Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53 in chronic myelogenous leukemia in acute phase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Bcl-2 blocks p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056825

10.3109/10428199509056825

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference